Overview

Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

Status:
Completed
Trial end date:
2017-03-02
Target enrollment:
Participant gender:
Summary
Bioequivalence Study of 2 formulation of metformin (Metformin GEROPHARM vers. Glucophage® Merck )
Phase:
Phase 1
Details
Lead Sponsor:
Geropharm
Treatments:
Metformin